Youngs Advisory Group, Inc. Amarin Corp Plcuk Transaction History

Youngs Advisory Group, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Jul 28, 2020	SELL	$4.78 - $8.26 $101,140 - $174,773	-21,159 Closed	0 $0
Q1 2020 Apr 28, 2020	BUY	$4.0 - $21.53 $4,000 - $21,530	1,000 Added 4.96%	21,159 $85,000
Q4 2018 Feb 12, 2019	BUY	$12.41 - $22.98 $126,073 - $233,453	10,159 Added 101.59%	20,159 $274,000
Q3 2017 Oct 24, 2017	BUY	$3.03 - $3.72 $30,299 - $37,200	10,000	10,000 $35,000

187

77.1M

247K

121K

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $250M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

Get notified when there are updates to the investment portfolio of Youngs Advisory Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Youngs Advisory Group, Inc. with notifications on news.